Related Experiment Video

Updated: May 19, 2026

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
06:27

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas

Published on: May 9, 2025

Mutant IDH1 is required for IDH1 mutated tumor cell growth

Genglin Jin1, Christopher J Pirozzi, Lee H Chen

  • 1The Preston Robert Tisch Brain Tumor Center, The Pediatric Brain Tumor Foundation Institute, and The Department of Pathology, Duke University Medical Center, Durham, North Carolina, USA.

Oncotarget
|August 14, 2012
PubMed

Insights

Targeting the mutant isocitrate dehydrogenase 1 (IDH1) protein may be a viable cancer therapy. Suppressing mutant IDH1 in fibrosarcoma cells significantly inhibited their growth and clonogenic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Somatic hotspot mutations in isocitrate dehydrogenase 1 (IDH1) are common in various cancers, including gliomas and acute myeloid leukemias.
  • These IDH1 mutations present a potential target for novel cancer therapies.
  • It remains unclear if the mutant IDH1 protein is essential for the sustained growth of IDH1-mutated tumor cells.

Purpose of the Study:

  • To investigate the necessity of endogenous mutant IDH1 protein for the proliferation and survival of cancer cells.
  • To evaluate the therapeutic potential of targeting mutant IDH1 in a relevant cellular model.

Main Methods:

  • Utilized a genetically engineered inducible system to selectively suppress endogenous mutant IDH1 expression.
  • Employed the HT1080 fibrosarcoma cell line, which harbors a native IDH1(R132C) heterozygous mutation.
  • Assessed the impact of mutant IDH1 suppression on cell proliferation and clonogenic potential.

Main Results:

  • Selective suppression of endogenous mutant IDH1 expression in HT1080 cells led to a significant inhibition of cell proliferation.
  • A decrease in the clonogenic potential of these cells was observed following mutant IDH1 suppression.
  • These results suggest that mutant IDH1 plays a crucial role in maintaining tumor cell growth.

Conclusions:

  • Mutant IDH1 protein is required for the proliferation and clonogenic potential of IDH1-mutated fibrosarcoma cells.
  • Targeting mutant IDH1 offers a promising therapeutic strategy for cancers harboring IDH1 mutations.
  • These findings provide a strong preclinical rationale for developing therapies aimed at mutant IDH1.

More Related Videos

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...